Gilead Sciences http://www.gilead.com/about/worldwide-operations/europe/greece EuroCharity's RSS for Gilead Sciences en 2010 2nd Tuesday of June 2020 10:16:32 PM 2nd Tuesday of June 2020 10:16:32 PM en 2010 Logo http://globalsustain.org/images/logos/gilead_logo3.jpg http://www.gilead.com/about/worldwide-operations/europe/greece Gilead Sciences: Profiles in Creating Possible - Staci Bush Helps Gilead Go Beyond Medicine to Address Barriers to HIV Care Through Partnerships http://globalsustain.org/en/story/15180 Read the full article here 2020-03-13 16:03:00 15180 2010-03-23T15:57:28Z Treatment With Gilead’s Vesatolimod Is Evaluated for Safety and Virologic and Immunologic Response Versus Placebo in Phase 1B HIV Functional Cure Study http://globalsustain.org/en/story/15210 Results Presented at CROI 2020 Support Further Evaluation of Vesatolimod as Part of Investigational Curative Regimens Aimed at Achieving ART-Free Control of HIV 2020-03-10 14:03:34 15210 2010-03-23T15:57:28Z Gilead Sciences: Innovation and Growth in Immuno-Oncology http://globalsustain.org/en/story/15136 Read the article by Daniel O’Day, Chairman and CEO of Gilead 2020-03-05 12:03:05 15136 2010-03-23T15:57:28Z Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19 http://globalsustain.org/en/story/15211 U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 2020-02-26 14:03:31 15211 2010-03-23T15:57:28Z Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University http://globalsustain.org/en/story/15212 These investigational agents have potential for use in HIV long-acting therapies for treatment and prevention, as well as cure strategies 2020-01-09 14:03:00 15212 2010-03-23T15:57:28Z